High hopes for new malaria vaccine based on blood protein

 

Science Editor

A new type of malaria vaccine based on proteins found in the blood of children who develop a natural resistance to the parasitic disease has been developed by American researchers.

Tests on laboratory mice have shown that the vaccine can protect the animals against the most lethal strains of malaria and scientists are confident that it will be both safe and effective in humans.

It is believed to be the first time that scientists have made a candidate malaria vaccine based on a blood protein that confers natural resistance to young children. The breakthrough could lead to the first clinical trials of the prototype vaccine within two years, the researchers said.

Malaria kills about 600,000 people each year, most of them young children under the age of five living in sub-Saharan Africa and South East Asia. There are more than 200 million cases a year worldwide and many children who survive infection can still be left with health problems in later life.

Scientists discovered the blood antibodies that confer natural resistance to malaria during a survey of about 785 children in Tanzania. About six per cent of the children possessed antibodies to a malaria protein that is vital for the parasite to complete its lifecycle within the human body.

Although the new candidate vaccine, known as PfSEA-1, has only been tested on mice, the scientists behind the research are excited about its potential in terms of protecting vulnerable children against the most dangerous forms of severe malaria.

The new PfSEA-1 vaccine works by trapping malaria parasites inside infected red blood cells so that they cannot emerge to infect other red blood cells and so complete their complicated life cycle, said Jonathan Kurtis at Rhode Island Hospital in the US.

“It turns out that antibodies to this protein prevent the schizont [a stage in the malaria lifecycle] from getting out of the red cell. We trap the parasite inside the red cell,” Dr Kurtis said.

 

“Most vaccine candidates for malaria have worked by trying to prevent parasites from entering red blood cells; we’ve taken a different approach. We’re sort of trapping the parasite in the burning house,” he said.

“We have found a way to block it from leaving the cell once it has entered. If it’s trapped in the red blood cells, it can’t go anywhere. It can’t do any further damage,” he added.

About 100 candidate malaria vaccines have been developed over the past 30 years but only one has made it to the final, phase-three stage of clinical trials. However, this vaccine, known as "RTS,S" and made by GlaxoSmithKline, confers less than 50 per cent protection – which many experts believe is better than none.

“Malaria is the single greatest killer of children on the planet. It kills one child every 15 seconds. It’s an unbelievable culling machine of sub-Sarharan Africa and South-East Asia. We need desperately a vaccine against malaria,” Dr Kurtis said.

“It’s unlikely that anything that is immediately on the horizon is going to be actually sufficient efficacious. So our next destination is an active vaccination trial in monkeys, followed by phase-one trials in humans. We’d like to roll this out as quickly as we can,” he said.

The study, published in the journal Science, showed that the PfSEA-1 vaccine can protect laboratory mice from the most severe strains of rodent malaria. The researchers also found that the children with PfSEA-1 antibodies naturally in their blood did not succumb to severe malaria, he added.

“The shocking result was that children who had detectable antibodies to this antigen never got severe malaria – zero cases,” Dr Kurtis said.

Some candidate vaccines have been shown to work well in animals such as mice and monkeys, but they fail to work in humans. This candidate vaccine comes from a natural protein that has been shown to confer high levels of resistance in children and so it should work in humans, he said.

“What really distinguishes this work is that we began with human beings and we can overcome the problem that says we’ve got a great vaccine, I can protect mice but it does not translate at all to human beings,” Dr Kurtis said.

Professor Mike Blackman, a malaria researcher at the National Institute for Medical Research in north London said: “The study is quite an important step forward and potentially raises the prospect of this becoming a vaccine candidate and combining it with other vaccine candidates… but they still have a long way to go.”

In 2011, scientists from the Wellcome Trust Sanger Institute in Cambridge identified the critical protein on the surface of red blood cells that allowed the malaria parasite to gain entry to the cell. The researchers said this protein, known as basigin, could also be used as a target for future prototype vaccines.

Combining two or more vaccines that target different stages of the malaria’s complicated lifecycle are likely to be more effective than just one vaccine, Dr Kurtis said. “We can approach the parasite from all angles,” he said.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Ashdown Group: Senior Accounts Assistant - Accounts Payable - St. Albans

£26000 - £28000 per annum + benefits : Ashdown Group: Senior Accounts Assistan...

Ashdown Group: Treasury Assistant - Accounts Assistant - London, Old Street

£24000 - £26000 per annum + benefits : Ashdown Group: A highly successful, glo...

Recruitment Genius: Installation and Service / Security Engineer

£22000 - £40000 per annum: Recruitment Genius: This company is part of a Group...

Recruitment Genius: Service Charge Accounts Assistant

£16000 - £18000 per annum: Recruitment Genius: Are you a a young, dynamic pers...

Day In a Page

General Election 2015: Chuka Umunna on the benefits of immigration, humility – and his leader Ed Miliband

Chuka Umunna: A virus of racism runs through Ukip

The shadow business secretary on the benefits of immigration, humility – and his leader Ed Miliband
Yemen crisis: This exotic war will soon become Europe's problem

Yemen's exotic war will soon affect Europe

Terrorism and boatloads of desperate migrants will be the outcome of the Saudi air campaign, says Patrick Cockburn
Marginal Streets project aims to document voters in the run-up to the General Election

Marginal Streets project documents voters

Independent photographers Joseph Fox and Orlando Gili are uploading two portraits of constituents to their website for each day of the campaign
Game of Thrones: Visit the real-life kingdom of Westeros to see where violent history ends and telly tourism begins

The real-life kingdom of Westeros

Is there something a little uncomfortable about Game of Thrones shooting in Northern Ireland?
How to survive a social-media mauling, by the tough women of Twitter

How to survive a Twitter mauling

Mary Beard, Caroline Criado-Perez, Louise Mensch, Bunny La Roche and Courtney Barrasford reveal how to trounce the trolls
Gallipoli centenary: At dawn, the young remember the young who perished in one of the First World War's bloodiest battles

At dawn, the young remember the young

A century ago, soldiers of the Empire – many no more than boys – spilt on to Gallipoli’s beaches. On this 100th Anzac Day, there are personal, poetic tributes to their sacrifice
Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves

Follow the money as never before

Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves, reports Rupert Cornwell
Samuel West interview: The actor and director on austerity, unionisation, and not mentioning his famous parents

Samuel West interview

The actor and director on austerity, unionisation, and not mentioning his famous parents
General Election 2015: Imagine if the leading political parties were fashion labels

Imagine if the leading political parties were fashion labels

Fashion editor, Alexander Fury, on what the leaders' appearances tell us about them
Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

The architect of the HeForShe movement and head of UN Women on the world's failure to combat domestic violence
Public relations as 'art'? Surely not

Confessions of a former PR man

The 'art' of public relations is being celebrated by the V&A museum, triggering some happy memories for DJ Taylor
Bill Granger recipes: Our chef succumbs to his sugar cravings with super-luxurious sweet treats

Bill Granger's luxurious sweet treats

Our chef loves to stop for 30 minutes to catch up on the day's gossip, while nibbling on something sweet
London Marathon 2015: Paula Radcliffe and the mother of all goodbyes

The mother of all goodbyes

Paula Radcliffe's farewell to the London Marathon will be a family affair
Everton vs Manchester United: Steven Naismith demands 'better' if Toffees are to upset the odds against United

Steven Naismith: 'We know we must do better'

The Everton forward explains the reasons behind club's decline this season
Arsenal vs Chelsea: Praise to Arsene Wenger for having the courage of his convictions

Michael Calvin's Last Word

Praise to Wenger for having the courage of his convictions